PL1831242T3 - Zmniejszanie zawartości zanieczyszczeń białkowych w kompozycjach zawierających zależne od witaminy K białko będące przedmiotem zainteresowania - Google Patents

Zmniejszanie zawartości zanieczyszczeń białkowych w kompozycjach zawierających zależne od witaminy K białko będące przedmiotem zainteresowania

Info

Publication number
PL1831242T3
PL1831242T3 PL05850495T PL05850495T PL1831242T3 PL 1831242 T3 PL1831242 T3 PL 1831242T3 PL 05850495 T PL05850495 T PL 05850495T PL 05850495 T PL05850495 T PL 05850495T PL 1831242 T3 PL1831242 T3 PL 1831242T3
Authority
PL
Poland
Prior art keywords
protein
vitamin
interest
compositions
reduction
Prior art date
Application number
PL05850495T
Other languages
English (en)
Inventor
Janus Krarup
Thomas Budde Hansen
Anne Charlotte Arentsen
Daniel E Rasmussen
Are Bogsnes
Arne Staby
Haleh Ahmadian
Susanne Bang
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of PL1831242T3 publication Critical patent/PL1831242T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
PL05850495T 2004-12-23 2005-12-23 Zmniejszanie zawartości zanieczyszczeń białkowych w kompozycjach zawierających zależne od witaminy K białko będące przedmiotem zainteresowania PL1831242T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200402008 2004-12-23
PCT/EP2005/057145 WO2006067230A1 (en) 2004-12-23 2005-12-23 Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
EP05850495A EP1831242B1 (en) 2004-12-23 2005-12-23 Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest

Publications (1)

Publication Number Publication Date
PL1831242T3 true PL1831242T3 (pl) 2013-04-30

Family

ID=36168465

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05850495T PL1831242T3 (pl) 2004-12-23 2005-12-23 Zmniejszanie zawartości zanieczyszczeń białkowych w kompozycjach zawierających zależne od witaminy K białko będące przedmiotem zainteresowania

Country Status (13)

Country Link
US (1) US9187549B2 (pl)
EP (2) EP1831242B1 (pl)
JP (2) JP2008525381A (pl)
KR (2) KR101364001B1 (pl)
CN (1) CN101098883B (pl)
AU (1) AU2005318106B2 (pl)
BR (1) BRPI0519626A2 (pl)
CA (1) CA2592054A1 (pl)
ES (1) ES2395544T3 (pl)
MX (1) MX2007007356A (pl)
PL (1) PL1831242T3 (pl)
RU (1) RU2460735C2 (pl)
WO (1) WO2006067230A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519626A2 (pt) 2004-12-23 2009-02-25 Novo Nordisk Healthcare Ag mÉtodos para a reduÇço do teor de um ou mais contaminantes, do teor de proteÍna s em uma composiÇço, do teor de um ou mais contaminantes de proteÍna em um sobrenadante de cultura de cÉlula, do teor de proteÍna s em um sobrenadante de cultura de cÉlula, composiÇço compreendendo uma proteÍna dependente de vitamina k de interesse
US7696318B2 (en) 2005-07-13 2010-04-13 Novo Nordisk Health Care Ag Host cell protein knock-out cells for production of therapeutic proteins
AT502691A1 (de) * 2005-10-24 2007-05-15 Univ Fuer Weiterbildung Krems Extrakorporales blut- oder plasmareinigungssystem
GB0710321D0 (en) * 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
US9956272B2 (en) 2007-05-30 2018-05-01 Bio Products Laboratory Limited Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
CN101730707B (zh) * 2007-07-11 2014-12-17 诺沃-诺迪斯克有限公司 使用混合式或多模式树脂来纯化因子ⅷ
TWI538916B (zh) 2008-04-11 2016-06-21 介控生化科技公司 經修飾的因子vii多肽和其用途
US20110287518A1 (en) * 2008-12-02 2011-11-24 Novo Nordisk Health Care A/G Polypeptide Purification
FR2946348B1 (fr) * 2009-06-05 2011-08-05 Lab Francais Du Fractionnement Procede de preparation d'une composition de complexe prothrombique a haut degre de purete
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
PL3715356T3 (pl) 2009-12-18 2024-03-11 Csl Limited Sposób oczyszczania polipeptydów
JP6250931B2 (ja) 2010-01-18 2017-12-20 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 血液凝固因子の精製
ES2610529T3 (es) * 2010-03-30 2017-04-28 Octapharma Ag Un procedimiento de purificación de proteínas dependientes de vitamina K, tales como el factor de coagulación IX
KR101780518B1 (ko) * 2010-04-29 2017-09-21 박스알타 인코퍼레이티드 음이온 교환 수지상에서의 2가 양이온 결합 단백질의 정제 방법
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
CN102161701A (zh) * 2011-01-28 2011-08-24 上海兴迪金生物技术有限公司 从细胞培养液或血浆组分中分离纯化高纯度活化凝血七因子的方法
JP2011172602A (ja) * 2011-06-15 2011-09-08 Jcr Pharmaceuticals Co Ltd 組換え体ヒトｆｓｈの製造方法
JP6236008B2 (ja) * 2011-10-14 2017-11-22 バクスアルタ ゲーエムベーハー アニオン交換クロマトグラフィーによるタンパク質の精製
EP2748180B1 (en) * 2011-10-14 2018-08-15 Baxalta GmbH Protein purification by anion exchange chromatography
HUE037677T2 (hu) 2013-03-15 2018-09-28 Baxalta Inc K-vitamin függõ fehérjék anioncserélõ kromatográfiás tisztítására szolgáló eljárás
DE112014002349B4 (de) 2013-05-10 2019-12-05 Denso Corporation Kraftstoffeinspritzsteuervorrichtung und Kraftstoffeinspritzsystem
JP5750471B2 (ja) * 2013-05-22 2015-07-22 Ｊｃｒファーマ株式会社 組換え体ヒトｆｓｈの製造方法
WO2016207328A1 (en) * 2015-06-24 2016-12-29 Glycotope Gmbh PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES
WO2018165936A1 (zh) * 2017-03-16 2018-09-20 深圳先进技术研究院 调节能量代谢的多肽及其用途
WO2018165933A1 (zh) * 2017-03-16 2018-09-20 深圳先进技术研究院 调节糖代谢的多肽及其用途
EP3590528A1 (en) * 2018-07-06 2020-01-08 Octapharma AG Fx activation process and its use in the preparation of a fxa composition
US20210069306A1 (en) 2019-08-15 2021-03-11 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration and on-demand treatment

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
EP0118256B1 (en) * 1983-03-04 1992-05-13 Scripps Clinic And Research Foundation Immunoadsorbent, and method of recovering vitamin-k dependent protein therewith
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
JPH0759600B2 (ja) 1986-12-15 1995-06-28 帝人株式会社 ヒト・プロテインｓに対するモノクローナル抗体
JPH01231893A (ja) 1988-03-14 1989-09-18 Fuji Yakuhin Kogyo Kk 抗ヒトプロテインｓモノクローナル抗体およびその利用
US4981952A (en) 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
US5077214A (en) 1989-07-07 1991-12-31 The Texas A&M University System Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells
JP2824430B2 (ja) 1989-08-02 1998-11-11 財団法人化学及血清療法研究所 血液凝固第▲ｖｉｉ▼因子または活性型血液凝固第▲ｖｉｉ▼因子の調製方法
US5580560A (en) 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
EP0658168B1 (en) * 1992-08-27 2000-11-15 Stichting Sanquin Bloedvoorziening Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
DK38293D0 (da) * 1993-03-31 1993-03-31 Novo Nordisk As Fremstilling af proteiner
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4406515C1 (de) 1994-02-28 1995-10-19 Immuno Ag Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
US6117996A (en) 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
GB9519197D0 (en) 1995-09-20 1995-11-22 Affinity Chromatography Ltd Novel affinity ligands and their use
DE19538715A1 (de) 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
JP3745805B2 (ja) * 1995-10-24 2006-02-15 日本ケミカルリサーチ株式会社 トロンボモジュリンの精製方法
PT1754718E (pt) 1996-04-24 2011-07-13 Univ Michigan Factor viii resistente à inactivação
US6017882A (en) 1997-10-23 2000-01-25 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
JP2000143692A (ja) 1998-11-11 2000-05-26 Fujimori Kogyo Co Ltd モノクローナル抗体によって精製されたトロンビン基質または阻害剤の精製方法
JP4732590B2 (ja) 1999-03-15 2011-07-27 ノボ ノルディスク アクティーゼルスカブ Ｇｌｐ−１及び近縁ペプチドのイオン交換クロマトグラフィー分離
EP1198565A1 (en) 1999-07-07 2002-04-24 Maxygen Aps A method for preparing modified polypeptides
JP4451514B2 (ja) 1999-08-24 2010-04-14 財団法人化学及血清療法研究所 血液凝固第ｖｉｉ因子改変体
RU2278123C2 (ru) 2000-02-11 2006-06-20 Максиджен Холдингз Лтд. Молекулы, подобные фактору vii или viia
SE0000675D0 (sv) * 2000-03-02 2000-03-02 Protease Ab Monoclonal antibodies
JP2001247599A (ja) 2000-03-07 2001-09-11 Fujimori Kogyo Co Ltd ポリペプチド、それを用いた血液凝固因子吸着体、該吸着体を用いた血液凝固因子の精製方法、および該ポリペプチドを含有する血栓形成予防剤
US6952212B2 (en) 2000-03-24 2005-10-04 Telefonaktiebolaget Lm Ericsson (Publ) Frame decimation for structure from motion
JP4455802B2 (ja) 2000-05-03 2010-04-21 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト ヒト第ｖｉｉ凝固因子変異型
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
US6423826B1 (en) 2000-06-30 2002-07-23 Regents Of The University Of Minnesota High molecular weight derivatives of vitamin K-dependent polypeptides
AU2001287550B2 (en) 2000-09-13 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor VII variants
KR100880624B1 (ko) * 2000-10-02 2009-01-30 노보 노르디스크 헬스 케어 악티엔게젤샤프트 비타민 ｋ-의존 단백질의 생산 방법
AU2002218029A1 (en) 2000-11-09 2002-05-21 The Scripps Research Institute Modified factor viia
RU2321633C2 (ru) * 2001-02-16 2008-04-10 Ново Нордиск Хелт Кэр Аг Способ получения витамин к-зависимых белков
HUP0401124A3 (en) 2001-03-22 2006-01-30 Novo Nordisk Healthcare Ag Coagulation factor vii derivatives
CA2461003A1 (en) 2001-09-27 2003-04-03 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
EP1434857B1 (en) 2001-10-02 2007-08-01 Novo Nordisk Health Care AG Method for production of recombinant proteins in eukaryote cells
PT2279753E (pt) 2001-10-10 2016-01-15 Novo Nordisk As Remodelação e glicoconjugação de péptidos
US7265084B2 (en) 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7125843B2 (en) 2001-10-19 2006-10-24 Neose Technologies, Inc. Glycoconjugates including more than one peptide
US7265085B2 (en) 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycoconjugation methods and proteins/peptides produced by the methods
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
DK1499719T3 (da) 2002-04-30 2011-02-28 Bayer Healthcare Llc Faktor VII- eller VIIa-polypeptidvarianter
US20050131005A1 (en) 2002-04-30 2005-06-16 Jiabing Wang 4-azasteroid derivatives as androgen receptor modulators
EP1546202B1 (en) 2002-09-25 2007-08-22 Novo Nordisk Health Care AG Human coagulation factor vii polypeptides
AU2003266931B2 (en) 2002-09-30 2010-01-21 Bayer Healthcare Llc FVII or FVIIa variants having increased clotting activity
BRPI0519626A2 (pt) 2004-12-23 2009-02-25 Novo Nordisk Healthcare Ag mÉtodos para a reduÇço do teor de um ou mais contaminantes, do teor de proteÍna s em uma composiÇço, do teor de um ou mais contaminantes de proteÍna em um sobrenadante de cultura de cÉlula, do teor de proteÍna s em um sobrenadante de cultura de cÉlula, composiÇço compreendendo uma proteÍna dependente de vitamina k de interesse

Also Published As

Publication number Publication date
AU2005318106B2 (en) 2011-11-03
JP2008525381A (ja) 2008-07-17
KR20070100732A (ko) 2007-10-11
KR20130128013A (ko) 2013-11-25
WO2006067230A1 (en) 2006-06-29
ES2395544T3 (es) 2013-02-13
RU2007122413A (ru) 2009-01-27
EP1831242A1 (en) 2007-09-12
US20080207880A1 (en) 2008-08-28
RU2460735C2 (ru) 2012-09-10
US9187549B2 (en) 2015-11-17
KR101364001B1 (ko) 2014-02-17
EP2360171A1 (en) 2011-08-24
MX2007007356A (es) 2007-08-14
JP2013100300A (ja) 2013-05-23
JP5866274B2 (ja) 2016-02-17
CN101098883B (zh) 2013-01-23
CA2592054A1 (en) 2006-06-29
BRPI0519626A2 (pt) 2009-02-25
CN101098883A (zh) 2008-01-02
EP1831242B1 (en) 2012-09-26
AU2005318106A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
PL1831242T3 (pl) Zmniejszanie zawartości zanieczyszczeń białkowych w kompozycjach zawierających zależne od witaminy K białko będące przedmiotem zainteresowania
GB0422525D0 (en) Dermatological compositions and methods
EP1750682A4 (en) NUTRITIONAL FORMULATIONS
PL1940240T3 (pl) Kompozycje izolatu białka i ich zastosowania
GB2412919B (en) Polishing composition and polishing method
ZA200800136B (en) Oxidation method and compositions thereof
EP1895838A4 (en) COMPOSITIONS AND METHODS
GB0505446D0 (en) Polishing composition and polishing method
SG115831A1 (en) Polishing composition and polishing method
GB0522287D0 (en) Method and compositions
EP1791855A4 (en) METHODS AND COMPOSITIONS ASSOCIATED WITH ARGONAUTE PROTEINS
GB0619096D0 (en) Polishing composition and polishing method
SG115786A1 (en) Polishing composition and polishing method
ZA200704295B (en) Arthrospira-based compositions and uses thereof
SG131098A1 (en) Polishing composition and polishing method
GB0516058D0 (en) New protein isoforms and uses thereof
IL184062A0 (en) Visco-supplement composition and methods
GB0524927D0 (en) Compositions and method
GB0417359D0 (en) Improvements in compositions
GB0422901D0 (en) Lipocalin protein
GB0401182D0 (en) Improvements in and relating to conveyors
GB0501348D0 (en) Compositions and methods
GB0511235D0 (en) Compositions and method
GB0419295D0 (en) Methods and compositions to prevent neuronal degeneration
ZA200706038B (en) Visco-supplement composition and methods